Orthocell Appoints Thailand Distributor for Remplir
Key points
- MediTime appointed as exclusive distributor in Thailand
- Access to US$84 million Thai nerve repair market
- Strengthens relationship with Device Technologies Group
Full summary
Orthocell Limited (ASX: OCC) has announced the appointment of MediTime as its exclusive distributor for the nerve repair product Remplir in Thailand. This move follows regulatory approval from the Thai Food and Drug Administration and aims to leverage MediTime's established network and expertise in orthopaedics and sports medicine to drive adoption of Remplir. MediTime, a subsidiary of Device Technologies Group, already supports Orthocell's distribution in Australia, New Zealand, and Singapore, extending the company's successful regional partnership. The appointment is part of Orthocell's broader strategy to expand its Asian market presence, with ongoing sales in Australia, Singapore, and Hong Kong.
Summary generated by a large language model. Please interpret with care.